Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Non-Current Assets: 2022-2024

Historic Non-Current Assets for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $7.0 million.

  • Orchestra BioMed Holdings' Non-Current Assets rose 4.03% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year increase of 4.03%. This contributed to the annual value of $7.0 million for FY2024, which is 14.82% up from last year.
  • According to the latest figures from FY2024, Orchestra BioMed Holdings' Non-Current Assets is $7.0 million, which was up 14.82% from $6.1 million recorded in FY2023.
  • In the past 5 years, Orchestra BioMed Holdings' Non-Current Assets ranged from a high of $10.9 million in FY2022 and a low of $6.1 million during FY2023.
  • Its 3-year average for Non-Current Assets is $8.0 million, with a median of $7.0 million in 2024.
  • Its Non-Current Assets has fluctuated over the past 5 years, first tumbled by 43.96% in 2023, then grew by 14.82% in 2024.
  • Yearly analysis of 3 years shows Orchestra BioMed Holdings' Non-Current Assets stood at $10.9 million in 2022, then plummeted by 43.96% to $6.1 million in 2023, then increased by 14.82% to $7.0 million in 2024.